Provided by Tiger Trade Technology Pte. Ltd.

Invivyd, Inc.

0.9965
+0.04574.81%
Post-market: 0.9588-0.0377-3.78%19:57 EDT
Volume:5.43M
Turnover:5.19M
Market Cap:293.97M
PE:-2.74
High:1.03
Open:0.9450
Low:0.8664
Close:0.9508
52wk High:3.07
52wk Low:0.5031
Shares:295.00M
Float Shares:208.00M
Volume Ratio:0.99
T/O Rate:2.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3641
EPS(LYR):-0.3048
ROE:-95.89%
ROA:-45.67%
PB:1.62
PE(LYR):-3.27

Loading ...

Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD), Traws Pharma (TRAW) and DocGo (DCGO)

TIPRANKS
·
Aug 18

Invivyd’s Nasdaq Listing at Risk: Potential Delisting Threatens Financing Access and Market Value

TIPRANKS
·
Aug 15

Invivyd (IVVD) Gets a Buy from Cantor Fitzgerald

TIPRANKS
·
Aug 14

Invivyd, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Invivyd Q2 EPS $(0.14) Misses $(0.11) Estimate, Sales $14.285M Miss $14.400M Estimate

Benzinga Earnings
·
Aug 14

Invivyd Q2 EPS USD -0.14

Reuters
·
Aug 14

Press Release: Invivyd Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Dow Jones
·
Aug 14

Invivyd, Inc. Expected to Post a Loss of 11 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Invivyd Files Form 3 for CMO, Chief Epidemiologist Michael Mina

Reuters
·
Aug 05

Invivyd Grants 277,500 Inducement Stock Options to New Hires at $0.54 Exercise Price

Reuters
·
Aug 04

Invivyd Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 04

Invivyd Gets NASDAQ Notice After Shares Trade Below $1 Minimum Bid Price

Reuters
·
Jul 25

Analysts Conflicted on These Healthcare Names: Cipher Pharmaceuticals (OtherCPHRF), Invivyd (IVVD) and Merck & Company (MRK)

TIPRANKS
·
Jul 09

Invivyd Price Target Maintained with a $10.00/share by BTIG

Dow Jones
·
Jul 07

FDA to End Emergency Use Authorization for Invivyd's Covid-19 Prevention Shot

Dow Jones
·
Jul 06

Invivyd announces notice of termination for Pemgarda Emergency Use Authorization

TIPRANKS
·
Jul 06

Invivyd Says FDA Sets June 29, 2027 Termination Date for Pemgarda EUA

Reuters
·
Jul 06

Invivyd - in Dialogue with FDA on Next Steps for Pemgarda

THOMSON REUTERS
·
Jul 06

Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (eua) Termination for Pemgarda® and Provides an Update on Next Steps with the U.S. FDA

THOMSON REUTERS
·
Jul 06

Invivyd - FDA to Terminate Pemgarda Eua Effective June 29, 2027

THOMSON REUTERS
·
Jul 06